Cite

HARVARD Citation

    Peyrin-Biroulet, L. et al. (n.d.). PWE-047 Improved patient-reported outcomes with upadacitinib over 52 weeks in patients with moderate-to-severe crohn's disease. Gut. p. A195. [Online]. 
  
Back to record